|
1
|
van der Knaap JA and Verrijzer CP:
Undercover: Gene control by metabolites and metabolic enzymes.
Genes Dev. 30:2345–2369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saadi H, Seillier M and Carrier A: The
stress protein TP53INP1 plays a tumor suppressive role by
regulating metabolic homeostasis. Biochimie. 118:44–50. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hostetler K: Chapter 6
polyglycerophospholipids: Phosphatidylglycerol,
diphosphatidylglycerol and bis, (monoacylglycero) phosphate. New
Compr Biochem. 4:215–261. 1982. View Article : Google Scholar
|
|
4
|
Hatch GM: Cell biology of cardiac
mitochondrial phospholipids. Biochem Cell Biol. 82:99–112. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang M, Mileykovskaya E and Dowhan W:
Gluing the respiratory chain together. Cardiolipin is required for
supercomplex formation in the inner mitochondrial membrane. J Biol
Chem. 277:43553–43556. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garrido C, Galluzzi L, Brunet M, Puig PE,
Didelot C and Kroemer G: Mechanisms of cytochrome C release from
mitochondria. Cell Death Differ. 13:1423–1433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ott M, Zhivotovsky B and Orrenius S: Role
of cardiolipin in cytochrome c release from mitochondria. Cell
Death Differ. 14:1243–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hostetler KY, Van den Bosch H and Van
Deenen LL: Biosynthesis of cardiolipin in liver mitochondria.
Biochim Biophys Acta. 239:113–119. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu B, Xu FY, Jiang YJ, Choy PC, Hatch GM,
Grunfeld C and Feingold KR: Cloning and characterization of a cDNA
encoding human cardiolipin synthase (hCLS1). J Lipid Res.
47:1140–1145. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Houtkooper RH, Akbari H, van Lenthe H,
Kulik W, Wanders RJ, Frentzen M and Vaz FM: Identification and
characterization of human cardiolipin synthase. FEBS Lett.
580:3059–3064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdollahi A and Omranipour R: Is increase
of homocysteine, anti-cardiolipin, anti-phospholipid antibodies
associated with breast tumors? Acta Med Iran. 53:681–685.
2015.PubMed/NCBI
|
|
12
|
Schvartsman G, Ferrarotto R and Massarelli
E: Checkpoint inhibitors in lung cancer: Latest developments and
clinical potential. Ther Adv Med Oncol. 8:460–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Santarpia M, Giovannetti E, Rolfo C,
Karachaliou N, González-Cao M, Altavilla G and Rosell R: Recent
developments in the use of immunotherapy in non-small cell lung
cancer. Expert Rev Respir Med. 10:781–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cufer T, Ovcaricek T and O'Brien ME:
Systemic therapy of advanced non-small cell lung cancer:
Major-developments of the last 5-years. Eur J Cancer. 49:1216–1225.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated Data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gyorffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shirlaw JT: The metabolism of tumors. Br
Med J. 1:741931. View Article : Google Scholar
|
|
21
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Veech RL: The therapeutic implications of
ketone bodies: The effects of ketone bodies in pathological
conditions: Ketosis, ketogenic diet, redox states, insulin
resistance and mitochondrial metabolism. Prostaglandins Leukot
Essent Fatty Acids. 70:309–319. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seyfried TN and Mukherjee P: Targeting
energy metabolism in brain cancer: Review and hypothesis. Nutr
Metab. 2:302005. View Article : Google Scholar
|
|
24
|
Wu M, Neilson A, Swift AL, Moran R,
Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J,
et al: Multiparameter metabolic analysis reveals a close link
between attenuated mitochondrial bioenergetic function and enhanced
glycolysis dependency in human tumor cells. Am J Physiol Cell
Physiol. 292:C125–C136. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Galarraga J, Loreck DJ, Graham JF, DeLaPaz
RL, Smith BH, Hallgren D and Cummins CJ: Glucose metabolism in
human gliomas: Correspondence of in situ and in vitro metabolic
rates and altered energy metabolism. Metab Brain Dis. 1:279–291.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baggetto LG, Clottes E and Vial C: Low
mitochondrial proton leak due to high membrane cholesterol content
and cytosolic creatine kinase as two features of the deviant
bioenergetics of Ehrlich and AS30-D tumor cells. Cancer Res.
52:4935–4941. 1992.PubMed/NCBI
|
|
27
|
Bergelson LD, Dyatlovitskaya EV, Sorokina
IB and Gorkova NP: Phospholipid compositon of mitochondria and
microsomes from regenerating rat liver and hepatomas of different
growth rate. Biochim Biophys Acta. 360:361–365. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chicco AJ and Sparagna GC: Role of
cardiolipin alterations in mitochondrial dysfunction and disease.
Am J Physiol Cell Physiol. 292:C33–C44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoch FL: Cardiolipins and biomembrane
function. Biochim Biophys Acta. 1113:71–133. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kiebish MA, Han X, Cheng H, Chuang JH and
Seyfried TN: Cardiolipin and electron transport chain abnormalities
in mouse brain tumor mitochondria: Lipidomic evidence supporting
the Warburg theory of cancer. J Lipid Res. 49:2545–2556. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hardy S, El-Assaad W, Przybytkowski E,
Joly E, Prentki M and Langelier Y: Saturated fatty acid-induced
apoptosis in MDA-MB-231 breast cancer cells. A role for
cardiolipin. J Biol Chem. 278:31861–31870. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mcmillin JB and Dowhan W: Cardiolipin and
apoptosis. Biochim Biophys Acta. 1585:97–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang B, Zhou Z, Lin H, Lv X, Fu J, Lin P,
Zhu C and Wang H: Protein phosphatase 1A (PPM1A) is involved in
human cytotrophoblast cell invasion and migration. Histochem Cell
Biol. 132:169–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li R, Gong Z, Pan C, Xie DD, Tang JY, Cui
M, Xu YF, Yao W, Pang Q, Xu ZG, et al: Metal-dependent protein
phosphatase 1A functions as an extracellular signal-regulated
kinase phosphatase. FEBS J. 280:2700–2711. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Su PH, Lin YW, Huang RL, Liao YP, Lee HY,
Wang HC, Chao TK, Chen CK, Chan MW, Chu TY, et al: Epigenetic
silencing of PTPRR activates MAPK signaling, promotes metastasis
and serves as a biomarker of invasive cervical cancer. Oncogene.
32:15–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blanco-Aparicio C, Torres J and Pulido R:
A novel regulatory mechanism of MAP kinases activation and nuclear
translocation mediated by PKA and the PTP-SL tyrosine phosphatase.
J Cell Biol. 147:1129–1136. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bhalla US, Ram PT and Iyengar R: MAP
kinase phosphatase as a locus of flexibility in a mitogen-activated
protein kinase signaling network. Science. 297:1018–1023. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bermudez O, Pagès G and Gimond C: The
dual-specificity MAP kinase phosphatases: Critical roles in
development and cancer. Am J Physiol Cell Physiol. 299:C189–C202.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Caunt CJ and Keyse SM: Dual-specificity
MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase
signalling. FEBS J. 280:489–504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ham JE, Oh EK, Kim DH and Choi SH:
Differential expression profiles and roles of inducible DUSPs and
ERK1/2-specific constitutive DUSP6 and DUSP7 in microglia. Biochem
Biophys Res Commun. 467:254–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huo Y, Rangarajan P, Ling EA and Dheen ST:
Dexamethasone inhibits the Nox-dependent ROS production via
suppression of MKP-1-dependent MAPK pathways in activated
microglia. BMC Neurosci. 12:492011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zeke A, Misheva M, Reményi A and
Bogoyevitch MA: JNK signaling: Regulation and functions based on
complex protein-protein partnerships. Microbiol Mol Biol Rev.
80:793–835. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Segalés J, Perdiguero E and Muñoz-Cánoves
P: Regulation of muscle stem cell functions: A focus on the p38
MAPK signaling pathway. Front Cell Dev Biol. 4:912016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schrauzer GN, White DA and Schnieder CJ:
Cancer mortality correlation studies-III: Statistical associations
with dietary selenium intakes. Bioinorg Chem. 7:23–31. 1997.
View Article : Google Scholar
|
|
48
|
Willis MS and Wians FH: The role of
nutrition in preventing prostate cancer: A review of the proposed
mechanism of action of various dietary substances. Clin Chim Acta.
330:57–83. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nyman DW, Stratton M Suzanne, Kopplin MJ,
Dalkin BL, Nagle RB and Jay Gandolfi A: Selenium and
selenomethionine levels in prostate cancer patients. Cancer Detect
Prev. 28:8–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Morey M, Corominas M and Serras F: DIAP1
suppresses ROS-induced apoptosis caused by impairment of the
selD/sps1 homolog in Drosophila. J Cell Sci. 116:4597–4604. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chung HJ, Yoon SI, Shin SH, Koh YA, Lee
SJ, Lee YS and Bae S: p53-Mediated enhancement of radiosensitivity
by selenophosphate synthetase 1 overexpression. J Cell Physiol.
209:131–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
